EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effect of the adenovirus E3/19k protein on antigen presentation in vivo



The effect of the adenovirus E3/19k protein on antigen presentation in vivo



Journal of Cellular Biochemistry Supplement 0(17 PART D): 55




(PDF emailed within 1 workday: $29.90)

Accession: 033785323

Download citation: RISBibTeXText



Related references

Disposition of antigen-presenting liposomes in vivo: effect on presentation of herpes simplex virus antigen rgD. Vaccine 12(3): 235-242, 1994

Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo. Journal of Virology 71(7): 5189-5196, 1997

Mhc class i restricted antigen presentation of a soluble protein delivered by liposomes in vitro and in vivo. FASEB Journal 6(5): A2062, 1992

Effect of HPV and squamous differentiation on antigen presentation in keratinocytes in vivo and in vitro. Journal of Investigative Dermatology 104(4): 627, 1995

Requirement of the T cell receptor for antigen presentation by T lymphocytes. Effect of envelope glycoproteins of HIV-1 on antigen presentation by T cells. Clinical and Experimental Immunology 80(2): 161-166, 1990

Antigen presentation after DNA vaccination Generation of immune responses by expression of a viral protein in muscle cells in vivo. Molecular Biology of the Cell 5(SUPPL ): 337A, 1994

The relationship between group C adenovirus tumor antigen and the adenovirus single-strand DNA-binding protein. Cell 7(4): 575-584, 1976

Production of a mono specific anti serum against the early region 1a proteins of adenovirus 12 and adenovirus 5 by an adenovirus 12 early region 1a beta galactosidase fusion protein antigen expressed in bacteria. Journal of Virology 50(3): 895-903, 1984

In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes. Journal of Immunology 165(11): 6123-6132, 2000

Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway. Plos Pathogens 5(10): E1000618-E1000618, 2009

CD154 -adenovirus enhancement of B-cell lymphoma antigen presentation. Blood 94(10 SUPPL 1 PART 1): 86a, Nov 15, 1999

In vivo association of adenovirus large E1A protein with the human mediator complex in adenovirus-infected and -transformed cells. Journal of Virology 76(18): 9186-9193, 2002

Regulation of molecules associated with antigen processing and presentation in cells transformed by adenovirus 12. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY [Author] The 9th International Congress of Immunology : 241, 1995

Antigen presentation by liver sinusoidal lining cells after antigen exposure in vivo. Journal of Immunology 138(5): 1377-1382, 1987